Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
Oncolytic measles virus (MV) strains have demonstrated broad spectrum preclinical anti-tumor, including breast cancer. Aurora A kinase controls mitotic spindle formation and plays a critical role in malignant transformation. We hypothesized that, by causing mitotic arrest, the Aurora A kinase inhibi...
Main Authors: | Iankov, Ianko D., Kurokawa, Cheyne B., D’Assoro, Antonio B., Ingle, James N., Domingo-Musibay, Evidio, Allen, Cory, Crosby, Catherine M., Nair, Asha A., Liu, Minetta C., Aderca, Ileana, Federspiel, Mark J., Galanis, Evanthia |
---|---|
Format: | Online |
Language: | English |
Published: |
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589445/ |
Similar Items
-
Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
by: Musibay, Evidio Domingo, et al.
Published: (2014) -
Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
by: Allen, Cory, et al.
Published: (2012) -
Aurora-A Kinase as a Promising Therapeutic Target in Cancer
by: D’Assoro, Antonino B., et al.
Published: (2016) -
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
by: Baldo, Aline, et al.
Published: (2015) -
ONCOLYTIC VIROTHERAPY
by: Russell, Stephen J, et al.
Published: (2012)